tirzepatide shortage fda update GLP-1 Saga Continues: Ends the FDA Announced Removal of Tirzepatide

And the body has not yet fully adapted its metabolic rate to the lower caloric intake

There are 1,831 more lawsuits in the MDL as of June 1st than there were on May 1, 2026

Doctors emphasize consulting them for appropriate use, as its not a casual weight-loss solution

Both versions use the same active ingredient, delivered through a once-weekly injection

While Novo Nordisk provides warning labels about common side effects of Wegovy and their other semaglutide medications, their labels may not provide adequate warning about severe health risks such as stomach paralysis, intestinal blockages, or bowel obstruction

Wait 30 seconds